13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001674546
申报总市值
US$47.5亿
US$47.5亿
161 檔
28.1%
Bellevue Group AG 在 Q4 2024 季度的美股仓位总计估值为 US$47.5亿，分散于 161 个持仓标的之中，反映其市场参与广度与投资规模。
在 Q4 2024，Bellevue Group AG 展现出较为审慎的避险与获利了结姿态。本季共减仓 68 个仓位并完全清仓 15 档持股，调降曝光的仓位数量高于加仓动作。
在资产配置集中度方面，Bellevue Group AG 的前 5 大核心持股（包含 ARGX, IONS, NBIX 等）合计占整体申报市值的 28.1%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ARGX | Argenx Se - Adr | 股票-医疗保健 | 7.02% | +0.44% | -6.26% | |
| 2 | IONS | Ionis Pharmaceuticals Inc | 股票-医疗保健 | 5.30% | -1.63% | -0.07% | |
| 3 | NBIX | Neurocrine Biosciences Inc | 股票-医疗保健 | 4.78% | +0.08% | -2.35% | |
| 4 | ISRG | Intuitive Surgical Inc | 股票-医疗保健 | 4.67% | -1.01% | -6.52% | |
| 5 | ITCIEUR | Intra-cellular Therapies Inc | 股票-其他 | 3.92% | — | -1.83% | |
| 6 | VRTX | Vertex Pharmaceuticals Inc | 股票-医疗保健 | 3.78% | -1.20% | -14.70% | |
| 7 | RVMD | Revolution Medicines Inc | 股票-医疗保健 | 3.69% | +0.56% | -9.95% | |
| 8 | ABT | Abbott Laboratories | 股票-医疗保健 | 3.68% | -1.00% | -3.17% | |
| 9 | BSX | Boston Scientific CORP | 股票-医疗保健 | 3.67% | -1.39% | -12.94% | |
| 10 | SYK | Stryker CORP | 股票-医疗保健 | 3.60% | +0.08% | -1.25% | |
| 11 | ALNY | Alnylam Pharmaceuticals Inc | 股票-医疗保健 | 3.49% | -1.84% | -4.80% | |
| 12 | INCY | Incyte CORP | 股票-医疗保健 | 2.87% | — | +0.32% | |
| 13 | AGIO | Agios Pharmaceuticals Inc | 股票-其他 | 2.22% | — | -5.91% | |
| 14 | SRRK | Scholar Rock Holding CORP | 股票-其他 | 2.09% | -1.36% | +16.17% | |
| 15 | PODD | Insulet CORP | 股票-医疗保健 | 1.62% | -0.41% | -23.62% | |
| 16 | MDT | Medtronic plc | 股票-医疗保健 | 1.60% | -0.33% | +3.40% | |
| 17 | EW | Edwards Lifesciences CORP | 股票-医疗保健 | 1.56% | -0.19% | -3.19% | |
| 18 | DXCM | Dexcom Inc | 股票-医疗保健 | 1.56% | -0.01% | +2.75% | |
| 19 | UNH | Unitedhealth Group Inc | 股票-医疗保健 | 1.56% | +0.35% | -29.19% | |
| 20 | CLDX | Celldex Therapeutics Inc | 股票-其他 | 1.49% | +0.03% | — | |
| 21 | BDX | Becton Dickinson And Co | 股票-医疗保健 | 1.47% | -0.11% | -0.03% | |
| 22 | BHVN | Biohaven Ltd. | 股票-其他 | 1.47% | — | — | |
| 23 | MRNA | Moderna Inc | 股票-医疗保健 | 1.28% | — | +0.00% | |
| 24 | PEN | Penumbra Inc | 股票-医疗保健 | 1.09% | -0.10% | EXIT | |
| 25 | WVE | Wave Life Sciences Ltd. | 股票-其他 | 0.97% | — | EXIT | |
| 26 | ARVN | Arvinas Inc | 股票-其他 | 0.88% | — | +0.13% | |
| 27 | GEHC | GE Healthcare Technology | 股票-医疗保健 | 0.79% | -0.37% | -1.42% | |
| 28 | EXK | Exact Sciences CORP | 股票-原材料 | 0.75% | — | -52.12% | |
| 29 | EWTX | Edgewise Therapeutics Inc | 股票-其他 | 0.73% | -1.15% | EXIT | |
| 30 | BEAM | Beam Therapeutics Inc | 股票-其他 | 0.72% | — | — | |
| 31 | PRCT | Procept Biorobotics CORP | 股票-其他 | 0.72% | -0.06% | -24.45% | |
| 32 | RMD | Resmed Inc | 股票-医疗保健 | 0.71% | -0.24% | +0.42% | |
| 33 | IMCR | Immunocore Holdings Plc-adr | 股票-其他 | 0.68% | -0.15% | — | |
| 34 | LLY | Eli Lilly & Co | 股票-医疗保健 | 0.68% | +0.01% | +2.76% | |
| 35 | CI | THE Cigna Group | 股票-医疗保健 | 0.67% | -0.23% | +5.74% | |
| 36 | ALGN | Align Technology Inc | 股票-医疗保健 | 0.64% | -0.07% | +11.12% | |
| 37 | COO | Cooper Cos Inc/the | 股票-医疗保健 | 0.63% | -0.16% | -10.13% | |
| 38 | MGNX | Macrogenics Inc | 股票-其他 | 0.62% | — | — | |
| 39 | IDXX | Idexx Laboratories Inc | 股票-医疗保健 | 0.61% | -0.51% | -15.71% | |
| 40 | TMO | Thermo Fisher Scientific Inc | 股票-医疗保健 | 0.61% | +0.09% | +13.69% | |
| 41 | ZBH | Zimmer Biomet Holdings Inc | 股票-医疗保健 | 0.60% | -0.10% | -32.16% | |
| 42 | RLAY | Relay Therapeutics Inc | 股票-其他 | 0.59% | +0.59% | +0.00% | |
| 43 | GMED | Globus Medical Inc - A | 股票-医疗保健 | 0.58% | -0.27% | -22.74% | |
| 44 | CDNA | Caredx Inc | 股票-其他 | 0.57% | — | -56.30% | |
| 45 | TNDM | Tandem Diabetes Care Inc | 股票-其他 | 0.54% | — | -57.73% | |
| 46 | DHR | Danaher CORP | 股票-医疗保健 | 0.53% | -0.33% | +13.57% | |
| 47 | INSP | Inspire Medical Systems Inc | 股票-医疗保健 | 0.53% | -0.12% | EXIT | |
| 48 | VEEV | Veeva Systems Inc-class A | 股票-医疗保健 | 0.52% | -0.02% | -21.98% | |
| 49 | ANNX | Annexon Inc | 股票-其他 | 0.51% | -0.19% | — | |
| 50 | VRNA | Verona Pharma PLC - Adr | 股票-其他 | 0.51% | — | -53.37% |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | SRRK | Scholar Rock Holding CORP | +1.8% | +16.17% | 加仓 |
| 2 | ARGX | Argenx Se - Adr | +1.5% | -6.26% | 减仓 |
| 3 | NBIX | Neurocrine Biosciences Inc | +1.3% | -2.35% | 减仓 |
| 4 | ITCIEUR | Intra-cellular Therapies Inc | +1% | -1.83% | 减仓 |
| 5 | ISRG | Intuitive Surgical Inc | +0.7% | -6.52% | 减仓 |
| 6 | INCY | Incyte CORP | +0.6% | +0.32% | 加仓 |
| 7 | SYK | Stryker CORP | +0.5% | -1.25% | 减仓 |
| 8 | DXCM | Dexcom Inc | +0.5% | +2.75% | 加仓 |
| 9 | ABT | Abbott Laboratories | +0.5% | -3.17% | 减仓 |
| 10 | MRK | Merck & Co. Inc. | +0.4% | +525.64% | 加仓 |
| 11 | WVE | Wave Life Sciences Ltd. | +0.4% | — | 不变 |
| 12 | BRKR | Bruker CORP | +0.4% | NEW | 新建仓 |
| 13 | EW | Edwards Lifesciences CORP | +0.4% | -3.19% | 减仓 |
| 14 | BSX | Boston Scientific CORP | +0.3% | -12.94% | 减仓 |
| 15 | AMGN | Amgen Inc | +0.3% | +254.80% | 加仓 |
| 16 | EHC | Encompass Health CORP | +0.3% | +880.20% | 加仓 |
| 17 | THC | Tenet Healthcare CORP | +0.3% | +1859.64% | 加仓 |
| 18 | PEN | Penumbra Inc | +0.2% | -12.70% | 减仓 |
| 19 | IONS | Ionis Pharmaceuticals Inc | +0.2% | -0.07% | 减仓 |
| 20 | NTRA | Natera Inc | +0.2% | +5.21% | 加仓 |
| 21 | ESPR | Esperion Therapeutics Inc | +0.2% | — | 不变 |
| 22 | BDX | Becton Dickinson And Co | +0.2% | -0.03% | 减仓 |
| 23 | MDT | Medtronic plc | +0.1% | +3.40% | 加仓 |
| 24 | BEAM | Beam Therapeutics Inc | +0.1% | — | 不变 |
| 25 | RVMD | Revolution Medicines Inc | +0.1% | -9.95% | 减仓 |
| 26 | EWTX | Edgewise Therapeutics Inc | +0.1% | — | 不变 |
| 27 | MGNX | Macrogenics Inc | +0.1% | — | 不变 |
| 28 | MASI* | Masimo CORP | +0.1% | NEW | 新建仓 |
| 29 | RMD | Resmed Inc | +0.1% | +0.42% | 加仓 |
| 30 | COR | Cencora Inc | +0.1% | +7.59% | 加仓 |
| 31 | MOH | Molina Healthcare Inc | +0.1% | +21.59% | 加仓 |
| 32 | IMCR | Immunocore Holdings Plc-adr | +0.1% | — | 不变 |
| 33 | TMO | Thermo Fisher Scientific Inc | +0.1% | +13.69% | 加仓 |
| 34 | STE | STERIS plc | +0.1% | +20.38% | 加仓 |
| 35 | SPY | Ss Spdr S&p 500 ETF Trust-us | +0.1% | NEW | 新建仓 |
| 36 | BTSG | Brightspring Health Services | +0.1% | NEW | 新建仓 |
| 37 | ALGN | Align Technology Inc | +0.1% | +11.12% | 加仓 |
| 38 | DHR | Danaher CORP | +0.1% | +13.57% | 加仓 |
| 39 | GKOS | Glaukos CORP | +0.1% | -3.35% | 减仓 |
| 40 | PRVA | Privia Health Group Inc | +0.1% | -10.01% | 减仓 |
| 41 | LLY | Eli Lilly & Co | 0% | +2.76% | 加仓 |
| 42 | GMED | Globus Medical Inc - A | 0% | -22.74% | 减仓 |
| 43 | SMMT | Summit Therapeutics Inc | 0% | +166.16% | 加仓 |
| 44 | BMRN | Biomarin Pharmaceutical Inc | 0% | -0.59% | 减仓 |
| 45 | WAY | Waystar Holding CORP | 0% | +5.12% | 加仓 |
| 46 | ALT | Altimmune Inc | 0% | +9.47% | 加仓 |
| 47 | PHR | Phreesia Inc | 0% | -3.96% | 减仓 |
| 48 | PODD | Insulet CORP | 0% | -23.62% | 减仓 |
| 49 | GILD | Gilead Sciences Inc | 0% | +5.22% | 加仓 |
| 50 | ANNX | Annexon Inc | 0% | — | 不变 |
根据 SEC 官方 Form 13F 申报备案，Bellevue Group AG 在 Q4 2024 季度的美股持仓总市值约为 US$47.5亿，共申报了 161 个公开持股仓位。
在 Q4 2024 季度，Bellevue Group AG 按市值排列的前三大核心持股分别为：ARGX (7.0%)、IONS (5.3%)、NBIX (4.8%)。其中最大持股仓位 ARGX 占据整体投资组合约 7.0% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
BRKR
市值: US$2107.9万
本季最大获利了结 / 清仓标的
OPCH
前期市值: US$5179.8万
在 Q4 2024 季度中，Bellevue Group AG 共进行了 146 项持仓异动，包含新建仓 13 个仓位、加仓 50 个仓位、减仓 68 个仓位以及清仓 15 个仓位。 其中最大新建仓标的为 BRKR。 本季清仓仓位包含 OPCH。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。